Manidón (Verapamil Hydrochloride)

Verapamil blocks L‑type calcium channels in cardiac muscle and vascular smooth muscle. By limiting calcium entry, it reduces myocardial contractility, slows conduction through the atrioventricular node, and causes arterial vasodilation. These actions collectively lower blood pressure, decrease oxygen demand of the heart, and help stabilize abnormal heart rhythms.

The appropriate dose of Manidón is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of verapamil during pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Manidón. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Manidón (verapamil) belongs to the calcium‑channel blocker class, which differs from ACE inhibitors, beta‑blockers, and diuretics in its mechanism of reducing calcium influx. It is particularly useful when vasodilation and heart‑rate control are desired, but may be less effective as monotherapy for some patients compared with agents that target the renin‑angiotensin system.

Manidón should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat, and direct sunlight to maintain potency throughout the shelf life.

Manidón is taken orally, usually with a glass of water. It can be administered with or without food, but consistency with meals may help reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless specifically instructed by a healthcare professional.

Serious risks include severe hypotension, marked bradycardia, heart block, and rare allergic reactions such as rash or anaphylaxis. Patients experiencing faintness, unusually slow heart rate, chest pain, or signs of an allergic response should seek immediate medical attention.

Manidón is contraindicated in patients with known hypersensitivity to verapamil or other calcium‑channel blockers, those with severe sinus bradycardia, second‑ or third‑degree AV block without a pacemaker, and patients in cardiogenic shock. It should also be avoided in individuals with uncontrolled heart failure unless closely monitored by a specialist.